Acadian Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Buy |
3,105
+978
| +46% | +$469K | ﹤0.01% | 1137 |
|
|
2026
Q1 | $1.04M | Sell |
2,127
-1,100
| -34% | -$597K | ﹤0.01% | 1149 |
|
|
2025
Q4 | $1.87M | Buy |
3,227
+843
| +35% | +$477K | ﹤0.01% | 937 |
|
|
2025
Q3 | $1.16M | Sell |
2,384
-2,513
| -51% | -$1.17M | ﹤0.01% | 1023 |
|
|
2025
Q2 | $1.98M | Sell |
4,897
-6,419
| -57% | -$2.68M | ﹤0.01% | 826 |
|
|
2025
Q1 | $5.63M | Sell |
11,316
-5,413
| -32% | -$2.93M | 0.02% | 479 |
|
|
2024
Q4 | $8.7M | Sell |
16,729
-4,748
| -22% | -$2.61M | 0.03% | 391 |
|
|
2024
Q3 | $13.3M | Buy |
21,477
+3,440
| +19% | +$2.04M | 0.04% | 300 |
|
|
2024
Q2 | $9.97M | Sell |
18,037
-6,543
| -27% | -$3.75M | 0.03% | 352 |
|
|
2024
Q1 | $14.3M | Buy |
24,580
+909
| +4% | +$510K | 0.05% | 239 |
|
|
2023
Q4 | $12.6M | Buy |
23,671
+17,180
| +265% | +$8.32M | 0.05% | 257 |
|
|
2023
Q3 | $3.28M | Sell |
6,491
-932
| -13% | -$497K | 0.01% | 554 |
|
|
2023
Q2 | $3.87M | Sell |
7,423
-937
| -11% | -$506K | 0.02% | 519 |
|
|
2023
Q1 | $4.82M | Sell |
8,360
-284
| -3% | -$160K | 0.02% | 465 |
|
|
2022
Q4 | $4.76M | Sell |
8,644
-434
| -5% | -$230K | 0.02% | 457 |
|
|
2022
Q3 | $4.6M | Buy |
9,078
+1,521
| +20% | +$851K | 0.03% | 418 |
|
|
2022
Q2 | $4.11M | Sell |
7,557
-6,192
| -45% | -$3.41M | 0.02% | 460 |
|
|
2022
Q1 | $8.12M | Sell |
13,749
-5,679
| -29% | -$3.26M | 0.03% | 356 |
|
|
2021
Q4 | $13M | Sell |
19,428
-8,224
| -30% | -$5.13M | 0.05% | 264 |
|
|
2021
Q3 | $15.8M | Sell |
27,652
-73,461
| -73% | -$40.3M | 0.06% | 243 |
|
|
2021
Q2 | $51M | Sell |
101,113
-144,187
| -59% | -$68M | 0.19% | 127 |
|
|
2021
Q1 | $112M | Buy |
245,300
+27,356
| +13% | +$13.1M | 0.44% | 58 |
|
|
2020
Q4 | $102M | Buy |
217,944
+100,068
| +85% | +$46.9M | 0.39% | 66 |
|
|
2020
Q3 | $52M | Buy |
117,876
+107,818
| +1,072% | +$44.5M | 0.22% | 103 |
|
|
2020
Q2 | $3.65M | Buy |
10,058
+3,439
| +52% | +$1.15M | 0.02% | 547 |
|
|
2020
Q1 | $1.88M | Buy |
6,619
+3,703
| +127% | +$1.17M | 0.01% | 622 |
|
|
2019
Q4 | $947K | Buy |
2,916
+1,881
| +182% | +$570K | ﹤0.01% | 891 |
|
|
2019
Q3 | $302K | Sell |
1,035
-2,265
| -69% | -$649K | ﹤0.01% | 1217 |
|
|
2019
Q2 | $969K | Sell |
3,300
-2,875
| -47% | -$792K | ﹤0.01% | 811 |
|
|
2019
Q1 | $1.69M | Sell |
6,175
-2,595
| -30% | -$646K | 0.01% | 731 |
|
|
2018
Q4 | $1.96M | Buy |
8,770
+7,748
| +758% | +$1.82M | 0.01% | 577 |
|
|
2018
Q3 | $249K | Hold |
1,022
| – | – | ﹤0.01% | 1038 |
|
|
2018
Q2 | $212K | Hold |
1,022
| – | – | ﹤0.01% | 1069 |
|
|
2018
Q1 | $211K | Sell |
1,022
-686
| -40% | -$144K | ﹤0.01% | 1044 |
|
|
2017
Q4 | $324K | Sell |
1,708
-1,520
| -47% | -$291K | ﹤0.01% | 885 |
|
|
2017
Q3 | $611K | Buy |
3,228
+2,206
| +216% | +$400K | ﹤0.01% | 757 |
|
|
2017
Q2 | $178K | Hold |
1,022
| – | – | ﹤0.01% | 960 |
|
|
2017
Q1 | $157K | Hold |
1,022
| – | – | ﹤0.01% | 1075 |
|
|
2016
Q4 | $144K | Buy |
+1,022
| New | +$151K | ﹤0.01% | 1056 |
|
|
2016
Q1 | – | Sell |
-64
| Closed | -$9K | – | 1492 |
|
|
2015
Q4 | $9K | Sell |
64
-2
| -3% | -$267 | ﹤0.01% | 1251 |
|
|
2015
Q3 | $8K | Sell |
66
-53
| -45% | -$6.91K | ﹤0.01% | 1163 |
|
|
2015
Q2 | $16K | Buy |
119
+2
| +2% | +$261 | ﹤0.01% | 1107 |
|
|
2015
Q1 | $16K | Sell |
117
-1,450
| -93% | -$187K | ﹤0.01% | 1133 |
|
|
2014
Q4 | $197K | Buy |
1,567
+1,514
| +2,857% | +$184K | ﹤0.01% | 887 |
|
|
2014
Q3 | $6K | Buy |
+53
| New | +$6.44K | ﹤0.01% | 922 |
|
Other funds holding TMO
Acadian Asset Management's TMO Position: Q2 2026 in Review
Acadian Asset Management increased its Thermo Fisher Scientific (TMO) stake by 46% in Q2 2026, buying an estimated $469K and bringing the position to 3,105 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1137.
Acadian Asset Management first reported a position in TMO in Q3 2014 and has held it in 45 quarters since. The position peaked at $112M in Q1 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Acadian Asset Management held 3,105 shares of Thermo Fisher Scientific worth $1.56M as of Q2 2026.
- Acadian Asset Management bought 978 Thermo Fisher Scientific shares in Q2 2026, an estimated $469K.
- Thermo Fisher Scientific made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1137 holding.
- Acadian Asset Management first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 45 quarters since.
- Acadian Asset Management's Thermo Fisher Scientific position peaked at $112M in Q1 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.